BioInsights - Modality/platform development trends - spotlight

IMMUNO-ONCOLOGY INSIGHTS

Modality/platform development trends

April 2023
Modality/platform development trends
Download PDF

Foreword

Spotlight on modality & platform development trends

Spotlight on modality & platform development trends

David Dilillo
2 May
Read

Commentary

Alloplex Biotherapeutic’s SUPLEXA cells represent a new type of autologous adoptive cellular therapy for cancer

Alloplex Biotherapeutic’s SUPLEXA cells represent a new type of autologous adoptive cellular therapy for cancer

Frank Borriello, James A Lederer
25 April
Read

Interview

Discovering cellular immunotherapy approaches in solid tumors & beyond

Discovering cellular immunotherapy approaches in solid tumors & beyond

Steven M Shamah
22 April
Read
Creating the next generation of antibodies for I–O

Creating the next generation of antibodies for I–O

Rony Dahan
16 April
Read

FastFacts

Al pathology in immuno-oncology research

Al pathology in immuno-oncology research

Marija Pezer
2 June
Read

Viewpoint

Advancing best-in-class allogeneic CAR-T therapies

Advancing best-in-class allogeneic CAR-T therapies

Blair Madison
16 April
Read